141 related articles for article (PubMed ID: 31957800)
1. Prefoldin subunits (PFDN1-6) serve as poor prognostic markers in gastric cancer.
Yesseyeva G; Aikemu B; Hong H; Yu C; Dong F; Sun J; Zang L; Zheng M; Ma J
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31957800
[TBL] [Abstract][Full Text] [Related]
2. Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.
Wang D; Shi W; Tang Y; Liu Y; He K; Hu Y; Li J; Yang Y; Song J
Oncogene; 2017 Feb; 36(7):885-898. PubMed ID: 27694898
[TBL] [Abstract][Full Text] [Related]
3. Prefoldin and prefoldin-like complex subunits as predictive biomarkers for hepatocellular carcinoma immunotherapy.
Zhao H; Chen C; Yang C; Mo S; Zhao H; Tian Y
Pathol Res Pract; 2022 Apr; 232():153808. PubMed ID: 35217267
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer.
Peñate X; Praena-Fernández JM; Romero Pareja P; Enguix-Riego MDV; Payán-Bravo L; Vieites B; Gomez-Izquierdo L; Jaen Olasolo J; Rivin Del Campo E; Reyes JC; Chávez S; Lopez Guerra JL
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32344577
[TBL] [Abstract][Full Text] [Related]
5. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
6. PFND1 Predicts Poor Prognosis of Gastric Cancer and Promotes Cell Metastasis by Activating the Wnt/β-Catenin Pathway.
Zhou C; Guo Z; Xu L; Jiang H; Sun P; Zhu X; Mu X
Onco Targets Ther; 2020; 13():3177-3186. PubMed ID: 32368077
[TBL] [Abstract][Full Text] [Related]
7. PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.
Wang P; Zhao J; Yang X; Guan S; Feng H; Han D; Lu J; Ou B; Jin R; Sun J; Zong Y; Feng B; Ma J; Lu A; Zheng M
Med Oncol; 2015 Dec; 32(12):264. PubMed ID: 26553318
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of signal transducers activators of transcription in gastric cancer.
Zhang Y; Yu C
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944204
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
11. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
12. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma.
Ke S; Lu S; Wang C; Xu Y; Bai M; Yu H; Feng Z; Yin B; Li Z; Huang J; Li X; Qian B; Hua Y; Pan S; Wu Y; Ma Y
Front Mol Biosci; 2022; 9():957001. PubMed ID: 36438659
[TBL] [Abstract][Full Text] [Related]
15. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
16. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
17. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
20. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
